Bayers’ revenues have mounted by 14.6% to €9.18 bl, largely due to growth in its consumer health and high-tech materials divisions. Net income has dropped to €525 mln, down from €532 mln a year earlieer.
For more details on Bayer reports solid Q2 revenues, Q2 sales rise 5.8% click here
No comments:
Post a Comment